Hedge fund billionaire Ray Dalio knows plenty about success: He founded Bridgewater Associates, the world’s largest hedge fund with roughly $160 billion in assets.
Keep Reading →
August 22 - Hedge Funds, Insider Trading
Apparently running for president is not a valid excuse for getting out of jury duty.
Keep Reading →
August 19 - Hedge Funds, Insider Trading
Niraparib, which goes by the brand name Zejula, is an once-daily oral PARP inhibitor.
Keep Reading →
March 28 - News
Lynparza, an ovarian cancer treatment developed by AstraZeneca PLC (ADR) (NYSE:AZN) has demonstrated its ability to slow down disease progression.
Keep Reading →
March 16 - News, Stock Analysis
It’s been a big week for PARP inhibitors.
Keep Reading →
March 15 - News, Stock Analysis
Trials of rival drugs from AstraZeneca PLC (ADR) (NYSE:AZN) and TESARO Inc (NASDAQ:TSRO) will determine the adoption of the PARP inhibitor, Rubraca from Clovis Oncology Inc (NASDAQ...
Keep Reading →
January 31 - News, Stock Analysis
Like Britain's decision to leave the EU, the unexpected occurred after Donald Trump beat Hillary Clinton to win the White House.
Keep Reading →
November 9 - Market Movers, News
Although the broader markets are only down moderately after today's rather disappointing jobs report, shares of five companies Clovis Oncology Inc (NASDAQ:CLVS), eBay Inc (NASDAQ...
Keep Reading →
October 7 - Market Movers, News
After being range-bound for the last few weeks, crude promises to be a little bit more volatile in the near-term following today's release of the EIA inventory numbers and the...
Keep Reading →
September 21 - Market Movers, News
Given the rising oil prices, it's not surprising that several oil stocks made it to our list of daily gainers.
Keep Reading →
September 8 - Commodities, Market Movers, News
Although Kyle Bass of Hayman Advisors is famous for his macro trading such as shorting Japanese bonds or the housing market, his fund also places equity bets too.
Keep Reading →
September 6 - Hedge Fund Analysis, Hedge Funds, News
Clovis Oncology Inc (NASDAQ:CLVS) is a biopharmaceutical company focused on developing and commercializing anti-cancer agents.
Keep Reading →
August 31 - News, Stock Analysis
Clovis Oncology Inc (NASDAQ:CLVS) just reported that the FDA has accepted its new drug application (NDA) and the company is up close to 30% ahead of the market open in the US ...
Keep Reading →
August 24 - News, Stock Analysis
Five stocks are in the spotlight following the release of their latest financial results, including DaVita HealthCare Partners Inc (NYSE:DVA), Colony Financial Inc (NYSE:CLNY...
Keep Reading →
August 9 - Earnings Report, News
Among the stocks showing more volatility than usual are TESARO Inc (NASDAQ:TSRO), Clovis Oncology Inc (NASDAQ:CLVS), PrivateBancorp Inc (NASDAQ:PVTB), Southwestern Energy Company...
Keep Reading →
June 29 - Commodities, Market Movers, News
Redmile Group is a San Francisco-based, healthcare-focused hedge fund founded and managed by Jeremy Green, an Oxford alum with more than 20 years of experience in wealth management...
Keep Reading →
June 3 - Hedge Fund Analysis, Hedge Funds, News
Although the CBOE Volatility Index is at 14 and crude prices are near their 2016 highs, volatility is of course alive and well among individual stocks.
Keep Reading →
April 13 - Market Movers, News
At a time when all three indexes are in the green, shares of Canadian Pacific Railway Limited (USA) (NYSE:CP), Norfolk Southern Corp.
Keep Reading →
April 11 - Market Movers, News
While the indexes have had a moderately volatile day so far, shares of Clovis Oncology Inc (NASDAQ:CLVS), China Hgs Real Estate Inc (NASDAQ:HGSH), Amira Nature Foods Ltd (NYSE...
Keep Reading →
April 8 - Market Movers, News
William Leland Edwards' Palo Alto Investors has about $2.22 billion worth of regulatory assets under its management.
Keep Reading →
March 2 - Hedge Funds, News
Redmile Group is a San Francisco-based investment firm managed by Jeremy Green, which primarily focuses on the healthcare sector.
Keep Reading →
February 26 - Hedge Funds, News
In the first part in our series, we covered five healthcare stocks that the hedge funds in our database have favored heavily for one reason or another, owning a high concentration...
Keep Reading →
December 13 - Hedge Funds, News
Palo Alto Investors, founded by Wall Street veteran William Leland Edwards in 1989, is one of the biggest healthcare investment shops in the United States, with over $2 billion...
Keep Reading →
December 1 - Hedge Fund Analysis, Hedge Funds, News
It is easy to imagine that hedge funds would not reveal their equity positions if it were not for reporting requirements enforced by the Securities and Exchange Commission.
Keep Reading →
November 20 - Hedge Fund Analysis, Hedge Funds, News
While Wall Street rallied into green territory from the opening bell on Monday, Dillard's Inc. (NYSE:DDS), Marriott International Inc.
Keep Reading →
November 16 - Earnings Report, Market Movers, News
As we have covered the top losers among healthcare stocks earlier today, which included three biotech companies, it's time to take a look at some companies that have been gaining...
Keep Reading →
September 9 - Hedge Funds, Market Movers, News
Headquartered in San Francisco, Partner Fund Management was established in 2004 by Christopher Medlock James.
Keep Reading →
April 18 - Hedge Funds, News, Tech
ABIOMED, Inc. (NASDAQ:ABMD) spiked as high as 21% in Tuesday's intraday trading to eventually close at 18% in the green at $72.48.
Keep Reading →
March 25 - Hedge Funds, Market Movers, News
Samuel Islay's Orbimed Advisors has revealed its equity portfolio as of end of 2014, in a recent filing with the Securities and Exchange Commission.
Keep Reading →
March 10 - Hedge Funds, News
Scott Sandell, a large shareholder and director with over 30 affiliations is the insider to watch for retail investors.
Keep Reading →
January 22 - Insider Trading, News
To the average investor, there are tons of methods shareholders can use to monitor the equity markets.
Keep Reading →
September 5 - News
To many market players, hedge funds are perceived as delayed, old financial tools of a period lost to current times.
Keep Reading →
September 3 - News
To the average investor, there are dozens of indicators market participants can use to analyze their holdings.
Keep Reading →
August 30 - News
Healthcare is the most happening industry these days with new drugs on the line and investors injecting cash into companies with greater speculative growth.
Keep Reading →
August 3 - News
Only a handful of stocks have gained 200% in 2013, and five of those stocks are in the biotechnology industry.
Keep Reading →
July 12 - News
Netflix, Inc. (NASDAQ:NFLX) has been a poster boy for market success in 2013.
Keep Reading →
June 25 - News
The healthcare industry is slowly becoming what the pre-crash technology industry was of the early 2000's.
Keep Reading →
June 18 - News
Public SEC filings from hedge funds and other notable investors can be useful sources of investment strategies and ideas for further research.
Keep Reading →
June 18 - Hedge Funds
Late last year, Clovis Oncology Inc (NASDAQ:CLVS) saw its share price cut in half, to $11.50, after reporting that its Phase 3 drug CO-101 failed to show a benefit over chemotherapy...
Keep Reading →
June 10 - News
Every week at The Motley Fool we reflect on the top stories in the biotech sector in a wrap-up column.
Keep Reading →
June 10 - News
Summer doesn't officially arrive for a few more weeks, but the first week of June packed some real heat.
Keep Reading →
June 10 - News
As I noted 12 weeks ago, cancer statistics are both staggering and disappointing.
Keep Reading →
June 6 - News
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
Keep Reading →
June 5 - News
Plenty of data was presented at the American Society for Clinical Oncology meeting over the weekend, causing the first set of ASCO pops, but Clovis Oncology Inc (NASDAQ:CLVS) ...
Keep Reading →
June 4 - News
To most stock holders, hedge funds are seen as underperforming, old financial tools of years past.
Keep Reading →
June 3 - News
For years, satirical late-night TV host Stephen Colbert has been running a series on his show called "Better Know a District," which highlights one of the 435 U.S.
Keep Reading →
March 12 - News
While the overall market seemed to be deciding this week whether to keep the rally going or take a break, several stocks in the world of health care left no doubt.
Keep Reading →
March 4 - News
Celgene Corporation (NASDAQ:CELG) announced on Wednesday a $600 million deal to buy a stake in a growing biotech with several successful products on the market and a strong pipeline...
Keep Reading →
February 20 - News
